These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 9019436)

  • 1. [Current status of frequency and complications of pelvic exenterations for recurrent cervico-uterine cancer after radiation].
    Torres-Lobatón A; González-Mendoza RL; Román-Bassaure E; Hernández-Aten D; Rojo-Herrera G
    Ginecol Obstet Mex; 1996 Dec; 64():538-43. PubMed ID: 9019436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indications for primary and secondary exenterations in patients with cervical cancer.
    Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A
    Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pelvic exenteration for cancer of the uterine cervix (prognostic factors)].
    Torres Lobatón A; Bastida Blanco A; Márquez Acosta G; Hernández Aten D; Román Bassaure E; Rojo Herrera G
    Ginecol Obstet Mex; 1994 Jul; 62():189-93. PubMed ID: 8063185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of pelvic exenterations in the treatment of cervix cancers. Apropos of 41 surgically treated cases].
    Janser JC; Rodier JF; Rodier D; Vergnes Y
    Chirurgie; 1994-1995; 120(8):409-14; 414-5. PubMed ID: 7648894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary pelvic exenteration in cervical cancer patients.
    Ungar L; Palfalvi L; Novak Z
    Gynecol Oncol; 2008 Nov; 111(2 Suppl):S9-12. PubMed ID: 18775558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ileal orthotopic neobladder after pelvic exenteration for cervical cancer.
    Chiva LM; Lapuente F; Núñez C; Ramírez PT
    Gynecol Oncol; 2009 Apr; 113(1):47-51. PubMed ID: 19176235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pelvic exenteration, morbidity and survival].
    Méndez L; Bernal A; Escudero P; González G; Fajardo A
    Ginecol Obstet Mex; 1994 Jun; 62():161-5. PubMed ID: 8056362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of operative laparoscopy in determining eligibility for pelvic exenteration in patients with recurrent cervical cancer.
    Plante M; Roy M
    Gynecol Oncol; 1995 Dec; 59(3):401-4. PubMed ID: 8522264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgery for the treatment of locally recurrent disease.
    Penalver MA; Barreau G; Sevin BU; Averette HE
    J Natl Cancer Inst Monogr; 1996; (21):117-22. PubMed ID: 9023840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pelvic exenterative procedures for locally advanced or recurrent colorectal carcinoma in a community hospital.
    Vitelli CE; Crenca F; Fortunato L; Di Nardo A; Farina M; Mustacciuoli G
    Tech Coloproctol; 2003 Oct; 7(3):159-63. PubMed ID: 14628159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laparoscopic pelvic exenteration for advanced pelvic cancers: a review of 16 cases.
    Puntambekar S; Kudchadkar RJ; Gurjar AM; Sathe RM; Chaudhari YC; Agarwal GA; Rayate NV
    Gynecol Oncol; 2006 Sep; 102(3):513-6. PubMed ID: 16510172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pelvic exenteration--indications, radical nature and follow-up demonstrated with 33 clinical cases].
    Kolbert G; Müller G; Kujath P; Bruch HP
    Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():1096-7. PubMed ID: 9574344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major morbidity after pelvic exenteration: a seven-year experience.
    Roberts WS; Cavanagh D; Bryson SC; Lyman GH; Hewitt S
    Obstet Gynecol; 1987 Apr; 69(4):617-21. PubMed ID: 3822305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Surgical treatment of recurrence of uterine cervix cancer].
    Dauplat J; Rodier JF; Issert B; Giraud B
    J Chir (Paris); 1986 Apr; 123(4):251-4. PubMed ID: 3745310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pelvic exenteration with curative intent for recurrent uterine malignancies.
    Khoury-Collado F; Einstein MH; Bochner BH; Alektiar KM; Sonoda Y; Abu-Rustum NR; Brown CL; Gardner GJ; Barakat RR; Chi DS
    Gynecol Oncol; 2012 Jan; 124(1):42-7. PubMed ID: 22014627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advanced cervico-uterine cancer. Experience with 162 pelvic exenterations].
    Rodríguez Cuevas H; Torres Lobatón A
    Ginecol Obstet Mex; 1976 Apr; 39(234):305-22. PubMed ID: 950146
    [No Abstract]   [Full Text] [Related]  

  • 18. Indications and long-term clinical outcomes in 282 patients with pelvic exenteration for advanced or recurrent cervical cancer.
    Schmidt AM; Imesch P; Fink D; Egger H
    Gynecol Oncol; 2012 Jun; 125(3):604-9. PubMed ID: 22406639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome.
    Callister M; Ramondetta LM; Jhingran A; Burke TW; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):786-96. PubMed ID: 14967435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resectability rates of previously irradiated recurrent cervical cancer (PIRCC) treated with pelvic exenteration: is still the clinical involvement of the pelvis wall a real contraindication? a twenty-year experience.
    Jurado M; Alcázar JL; Martinez-Monge R
    Gynecol Oncol; 2010 Jan; 116(1):38-43. PubMed ID: 19878978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.